ABCC4 and rectal cancer: Significant association between downregulation of ABCC4 and sensitivity to neoadjuvant chemo-radiotherapy, as well as between low ABCC4 expression and longer disease-free survival in rectal cancer patients has been demonstrated18, 19, indicating that ABCC4 might be a possible predictive biomarker for the efficacy of chemotherapy in CRC.